Jb Capital LLC Danaher Corp Transaction History

Jb Capital LLC

$1.76 Billion
Q4 2024

A detailed history of Jb Capital LLC transactions in Danaher Corp stock. As of the latest transaction made, Jb Capital LLC holds 959 shares of DHR stock, worth $197,256. This represents 0.01% of its overall portfolio holdings.

Number of Shares

959

Previous 975 1.64%

Holding current value

$197,256

Previous $271,000 18.82%

% of portfolio

0.01%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	SELL	$226.16 - $274.52 $3,618 - $4,392	-16 Reduced 1.64%	959 $220,000
Q3 2024 Oct 31, 2024	BUY	$239.25 - $280.76 $2,153 - $2,526	9 Added 0.93%	975 $271,000
Q2 2024 Jul 24, 2024	BUY	$235.51 - $267.98 $8,007 - $9,111	34 Added 3.65%	966 $241,000
Q1 2024 Apr 30, 2024	BUY	$224.58 - $256.19 $449 - $512	2 Added 0.22%	932 $232,000
Q4 2023 Jan 22, 2024	BUY	$185.1 - $233.13 $2,036 - $2,564	11 Added 1.2%	930 $215,000
Q2 2023 Jul 25, 2023	SELL	$224.99 - $256.14 $449 - $512	-2 Reduced 0.22%	919 $220,000
Q1 2023 Apr 25, 2023	SELL	$239.75 - $277.0 $24,454 - $28,254	-102 Reduced 9.97%	921 $232,000
Q4 2022 Jan 23, 2023	SELL	$241.42 - $282.29 $1,689 - $1,976	-7 Reduced 0.68%	1,023 $0
Q3 2022 Oct 14, 2022	SELL	$247.06 - $1507.4 $217,906 - $1.33 Million	-882 Reduced 46.13%	1,030 $266,000
Q2 2022 Jul 28, 2022	BUY	$237.11 - $299.66 $120,451 - $152,227	508 Added 36.18%	1,912 $485,000
Q1 2022 Apr 19, 2022	SELL	$257.27 - $315.76 $125,805 - $154,406	-489 Reduced 25.83%	1,404 $412,000
Q4 2021 Feb 02, 2022	BUY	$292.08 - $329.01 $5,841 - $6,580	20 Added 1.07%	1,893 $622,000
Q3 2021 Dec 08, 2021	BUY	$272.21 - $332.43 $509,849 - $622,641	1,873 New	1,873 $570,000

Others Institutions Holding DHR

# of Institutions

2,545

Shares Held

556M

Call Options Held

7.24M

Put Options Held

4.28M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $150B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jb Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jb Capital LLC with notifications on news.

Account